Munafa Stock Market Course + Intraday & FNO calls 
Glaxosmithkline Plc (GSK) Technical (Analysis) Reports Glaxosmithkline Plc ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Glaxosmithkline Plc (GSK)
Technical Analysis Report for USA stock GSK Glaxosmithkline Plc. Dated: 03 Mar 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock GSK Glaxosmithkline Plc then click here. or read Experts views on Glaxosmithkline Plc or Forecast & share price targets of Glaxosmithkline Plc
Glaxosmithkline Plc Opened at 56.82 and Closed at: 57.07, which is -2.14% of previous session's close. It moved within a range of 56.16 and 57.35
The session was a Bullish session with an average volume of 3914000, which is 19.07% of previous session's volumes.
- Even though the stock has fallen, but its short term trend is positive and in an uptrend.
- Even though the stock has fallen, but its mid term trend is positive and in an uptrend.
- Even though the stock has fallen, but its long term trend is positive and in an uptrend.
Support for tomorrow is 56.62 and resistance for tomorrow is 57.81
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 56.37, 55.67 resistance for tomorrow's hourly charts is 57.56, 58.05
10 Day SMA for Glaxosmithkline Plc (GSK) is 59.2 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Glaxosmithkline Plc (GSK) is 59.11 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Glaxosmithkline Plc (GSK) is 53.51 and the stock is trading above these levels. This is a good sign for its mid to long term trend
100 Day SMA is 50.08 and the stock is trading above these levels. This is a good sign for its long term trend
200 Day SMA Glaxosmithkline Plc is 44.7 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Glaxosmithkline Plc is at 59.11 and 200 DMA is at 44.7, while 50 DMA and 100 DMA are at 53.51 and 50.08 respectively
Glaxosmithkline Plc (GSK) moving average of 20 SMA is at 59.11 and 20 EMA is at 57.8
| Date | Closing Price | 20 SMA | 20 EMA |
| 03 Tue Mar | 57.07 | 59.11 | 57.8 |
| 02 Mon Mar | 58.29 | 58.93 | 57.88 |
| 27 Fri Feb | 59.13 | 58.64 | 57.84 |
| 26 Thu Feb | 58.07 | 58.26 | 57.7 |
| 25 Wed Feb | 59.54 | 57.89 | 57.66 |
| 24 Tue Feb | 59.12 | 57.42 | 57.46 |
Glaxosmithkline Plc (GSK) moving average of 50 SMA is at 53.51 and 50 EMA is at 54.53
| Date | Closing Price | 50 SMA | 50 EMA |
| 03 Tue Mar | 57.07 | 53.51 | 54.53 |
| 02 Mon Mar | 58.29 | 53.33 | 54.43 |
| 27 Fri Feb | 59.13 | 53.14 | 54.27 |
| 26 Thu Feb | 58.07 | 52.93 | 54.07 |
| 25 Wed Feb | 59.54 | 52.76 | 53.91 |
| 24 Tue Feb | 59.12 | 52.54 | 53.68 |
Glaxosmithkline Plc (GSK) moving average of 100 SMA is at 50.08 and 100 EMA is at 50.87
| Date | Closing Price | 100 SMA | 100 EMA |
| 03 Tue Mar | 57.07 | 50.08 | 50.87 |
| 02 Mon Mar | 58.29 | 49.94 | 50.74 |
| 27 Fri Feb | 59.13 | 49.79 | 50.59 |
| 26 Thu Feb | 58.07 | 49.66 | 50.42 |
| 25 Wed Feb | 59.54 | 49.51 | 50.27 |
| 24 Tue Feb | 59.12 | 49.32 | 50.08 |
Glaxosmithkline Plc (GSK) moving average of 200 SMA is at 44.7 and 200 EMA is at 46.81
| Date | Closing Price | 200 SMA | 200 EMA |
| 03 Tue Mar | 57.07 | 44.7 | 46.81 |
| 02 Mon Mar | 58.29 | 44.59 | 46.71 |
| 27 Fri Feb | 59.13 | 44.49 | 46.59 |
| 26 Thu Feb | 58.07 | 44.38 | 46.46 |
| 25 Wed Feb | 59.54 | 44.27 | 46.34 |
| 24 Tue Feb | 59.12 | 44.17 | 46.21 |
Penumbra Inc has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Penumbra Inc, about 0.35% more returns!
Encompass Health has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Encompass Health, about 13.19% more returns!
Glaxosmithkline Plc has performed better than Therapeuticsmd Inc in short term. Holding Glaxosmithkline Plc could be a better choice for now!
Staar Surgical has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Staar Surgical, about 8.15% more returns!
Masimo Corporation has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Masimo Corporation, about 28.64% more returns!
Kodiak Sciences has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Kodiak Sciences, about 18.42% more returns!
Kamada has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Kamada, about 10.53% more returns!
Glaxosmithkline Plc has performed better than Iterum Therapeutics in short term. Holding Glaxosmithkline Plc could be a better choice for now!
Glaxosmithkline Plc has performed better than Incyte Corporation in short term. Holding Glaxosmithkline Plc could be a better choice for now!
Henry Schein has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Henry Schein, about 6.86% more returns!
Glaxosmithkline Plc has performed better than Grifols S in short term. Holding Glaxosmithkline Plc could be a better choice for now!
Fonar Corporation has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Fonar Corporation, about 0.17% more returns!
Corbus Pharmaceuticals has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Corbus Pharmaceuticals, about 2.78% more returns!
Biomarin Pharmaceutical has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Biomarin Pharmaceutical, about 1.86% more returns!
Glaxosmithkline Plc has performed better than Axogen Inc in short term. Holding Glaxosmithkline Plc could be a better choice for now!
Ascendis Pharma has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Ascendis Pharma, about 9.15% more returns!
Glaxosmithkline Plc has performed better than Argenx Se in short term. Holding Glaxosmithkline Plc could be a better choice for now!
Glaxosmithkline Plc has performed better than Apellis Pharmaceuticals in short term. Holding Glaxosmithkline Plc could be a better choice for now!
Amgen Inc has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Amgen Inc, about 3.23% more returns!
Glaxosmithkline Plc Technical analysis of indicators
Price action analysis of Glaxosmithkline Plc (GSK) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Glaxosmithkline Plc stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Glaxosmithkline Plc in short term but the sell signal is initial and weak.
Glaxosmithkline Plc Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Glaxosmithkline Plc in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Glaxosmithkline Plc is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 59.27 and Glaxosmithkline Plc GSK stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Glaxosmithkline Plc GSK stock. Volume based technical analysis of Glaxosmithkline Plc GSK stock is negative.
Glaxosmithkline Plc Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock GSK Glaxosmithkline Plc These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And GSK Experts View which covers a lot of information including buying and selling signals
GSK future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Glaxosmithkline Plc or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Glaxosmithkline Plc (GSK) Technical (Analysis) Reports Glaxosmithkline Plc ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
